Avantor, Inc. (AVTR)
NYSE: AVTR · Real-Time Price · USD
20.36
+0.22 (1.09%)
Nov 21, 2024, 4:00 PM EST - Market closed

Company Description

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies.

In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services.

Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services.

The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Avantor, Inc.
Avantor logo
Country United States
Founded 1904
IPO Date May 17, 2019
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 7,570
CEO Michael Stubblefield

Contact Details

Address:
Radnor Corporate Center, Building One
Radnor, Pennsylvania 19087
United States
Phone 610 386 1700
Website avantorsciences.com

Stock Details

Ticker Symbol AVTR
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
IPO Price $14.00
CIK Code 0001722482
CUSIP Number 05352A100
ISIN Number US05352A1007
Employer ID 82-2758923
SIC Code 3826

Key Executives

Name Position
Michael Stubblefield President, Chief Executive Officer and Director
R. Brent Jones Executive Vice President and Chief Financial Officer
James Bramwell Executive Vice President of Sales and Customer Excellence
Steven W. Eck Senior Vice President, Corporate Controller and Chief Accounting Officer
Michael Wondrasch Executive Vice President and Chief Information Officer
Christina Jones Vice President of Investor Relations
Claudius O. Sokenu Executive Vice President, Corporate Secretary and Chief Legal and Compliance Officer
Allison K. Hosak Senior Vice President of Global Communications and Brand
Kitty Sahin Executive Vice President of Strategy and Corporate Development
Brittany Hankamer Executive Vice President and Chief Human Resources Officer

Latest SEC Filings

Date Type Title
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 6, 2024 8-K Current Report
Oct 25, 2024 10-Q Quarterly Report
Oct 25, 2024 8-K Current Report
Sep 5, 2024 144 Filing
Aug 26, 2024 144 Filing
Aug 9, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Aug 7, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jul 31, 2024 144 Filing
Jul 30, 2024 144 Filing